Tango Therapeutics Files $500 Million Common Stock Offering
Tango Therapeutics (NASDAQ: TNGX) announced a public offering of up to $500 million in common stock, with an option for underwriters to purchase additional shares worth up to $75 million. The move is expected to raise significant capital but may dilute existing shareholders.
Tickers: $TNGX